ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
6.75
-0.24 (-3.43%)
Dec 31, 2025, 1:40 PM EST - Market open
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $14.53 million as of December 31, 2025. Its market cap has decreased by -52.72% in one year.
Market Cap
14.53M
Enterprise Value
-386.63K
1-Year Change
-52.72%
Ranking
Category
Stock Price
$6.75
Market Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has decreased from $21.82M to $14.53M, a decrease of -33.42%. That is a compound annual growth rate of -2.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 15.05M | -51.44% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |